Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are common critical diseases. Bone marrow mesenchymal stem cell (BMSC) transplantation is previously shown to effectively rescue injured lung tissues. The therapeutic mechanism of BMSC‐derived exosomes is not fully understood. Here, we investigated the BMSC‐derived exosomal microRNAs (miRNAs) on effecting lipopolysaccharide‐ (LPS‐) induced ALI and its mechanism. In vitro, rat alveolar macrophages were treated with or without exosomes in the presence of 10 μg/ml LPS for 24 h. Cell viability was determined with Cell Counting Kit‐8 assay. Apoptotic ratio was determined with TUNEL and Annexin V‐FITC/PI double staining. The levels of miR‐384‐5p and autophagy‐associated genes were measured by RT‐qPCR and western blot. Autophagy was observed by TEM and assessed by means of the mRFP‐GFP‐LC3 adenovirus transfection assay. In vivo, we constructed LPS‐induced ALI rat models. Exosomes were injected into rats via the caudal vein or trachea 4 h later after LPS treatment. The lung histological pathology was determined by H&E staining. Pulmonary vascular permeability was assessed by wet‐to‐dry weight ratio and Evans blue dye leakage assay, and inflammatory cytokines in serum and BALF were measured by ELISA. Furthermore, the therapeutic mechanism involved in miR‐384‐5p and Beclin‐1 was determined. The results showed that BMSC‐derived exosomes were taken up by the alveolar macrophages and attenuated LPS‐induced alveolar macrophage viability loss and apoptosis. Exosomes effectively improved the survival rate of ALI rats within 7 days, which was associated with alleviating lung pathological changes and pulmonary vascular permeability and attenuating inflammatory response. Furthermore, this study for the first time found that miR‐384‐5p was enriched in BMSC‐derived exosomes, and exosomal miR‐384‐5p resulted in relieving LPS‐injured autophagy disorder in alveolar macrophages by targeting Beclin‐1. Therefore, exosomal miR‐384‐5p could be demonstrated as a promising therapeutic strategy for ALI/ARDS.
Background. Of all intestinal microbiome-derived metabolites, trimethylamine N-oxide (TMAO) has received increasing attention because of its potent role in colorectal cancer development. Accumulating evidence suggests that TMAO generated by the gut microbiota is a new and important player in the etiological process of colorectal cancer. Nevertheless, the carcinogenic mechanism of TMAO in colorectal cancer remains unclear. In this study, TMAO induced colorectal cancer cell proliferation and produced higher vascular endothelial growth factor A (VEGFA) levels in vitro. In vivo, after long-term choline feeding in tumor-bearing mice, circulating TMAO levels, tumor volume, new blood vessel formation, and VEGFA and CD31 amounts were increased significantly. This study revealed that TMAO exerts oncogenic effects by promoting cell proliferation and angiogenesis in colorectal cancer.
Background: Microglia activation is associated with the development of hypoxic–ischemic brain injury (HIBI). Neuroinflammation suppression might be a suitable therapeutic target in hypoxic oligodendrocyte injury. This study aims to determine whether clemastine can improve hypomyelination by suppressing the activated microglia and promoting the maturation of oligodendrocyte progenitor cells (OPCs) in HIBI. Methods: A bilateral common carotid artery occlusion (BCCAO) rat model that received continuous intraperitoneal injection (1 mg/kg) for 14 days was employed to elaborate the neuroprotection effects of clemastine. Interleukin-1β (IL-1β), nod-like receptor protein 3 (NLRP3), histamine H1 receptor, and OPC differentiation levels in the corpus callosum were measured. Primary cultured OPCs and co-culture of microglia and OPCs were used to explore the link between microglia activation and hypomyelination. Data were evaluated by one-way ANOVA with Fisher’s protected least significant difference test. Results: Clemastine treatment could reverse hypomyelination and restrain the upregulation of IL-1β and NLRP3 in the corpus callosum of BCCAO rats. Primary cultured OPCs treated with IL-1β showed failed maturation. However, clemastine could also reverse the OPC maturation arrest by activating the extracellular signal-regulated kinase (ERK) signaling pathway. Co-culture of microglia and OPCs with oxygen glucose deprivation treatment exhibited IL-1β and NLRP3 upregulation. Clemastine could downregulate NLRP3 and IL-1β and reverse hypomyelination by inhibiting the p38 signaling pathway. Conclusions: Clemastine could restrain microglia activation, improve axonal hypomyelination in BCCAO rats, and thus might be a viable strategy to inhibit hypomyelination in the corpus callosum of patients with HIBI.
Introduction: Intestinal barrier dysfunction is a pivotal factor in sepsis progression. The mechanosensitive ion channel Piezo1 is associated with barrier function; however, its role in sepsis-induced intestinal barrier dysfunction remains poorly understood. Methods: The application of cecal ligation and puncture (CLP) modeling was performed on both mice of the wild-type (WT) variety and those with Villin-Piezo1flox/flox genetic makeup to assess the barrier function using in vivo FITC-dextran permeability measurements and immunofluorescence microscopy analysis of tight junctions (TJs) and apoptosis levels. In vitro, Caco-2 monolayers were subjected to TNF-α incubation. Moreover, to modulate Piezo1 activation, GsMTx4 was applied to inhibit Piezo1 activation. The barrier function, intracellular calcium levels, and mitochondrial function were monitored using calcium imaging and immunofluorescence techniques. Results: In the intestinal tissues of CLP-induced septic mice, Piezo1 protein levels were notably elevated compared with those in normal mice. Piezo1 has been implicated in the sepsis-mediated disruption of TJs, apoptosis of intestinal epithelial cells, elevated intestinal mucosal permeability, and systemic inflammation in WT mice, whereas these effects were absent in Villin-Piezo1flox/flox CLP mice. In Caco-2 cells, TNF-α prompted calcium influx, an effect reversed by GsMTx4 treatment. Elevated calcium concentrations are correlated with increased accumulation of reactive oxygen species, diminished mitochondrial membrane potential, and TJ disruption. Conclusions: Thus, Piezo1 is a potential contributor to sepsis-induced intestinal barrier dysfunction, influencing apoptosis and TJ modification through calcium influx-mediated mitochondrial dysfunction.
1 January 2022 in Journal of Inflammation Research
Background: A modified scoring system based on the RDW, AGE, SOFA, and APACHE II score (RAAS score) was composed to investigated the short-, medium-, and long-term high risk of mortality in patients with sepsis identified early in the emergency department (ED). Methods: Data were collected from a total of 1066 sepsis patients in emergency department, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from March 2013 to April 2021, including 529 patients in the primary cohort and 537 patients in the validation cohort. By comparing each parameter and the area under ROC (AUC) and K-M (Kaplan–Meier) survival curve in different periods, valuable parameters were screened out to form a new scoring system, and finally the prediction model of the nomogram was built. Results: The RAAS scoring system, consisting of RDW, AGE, SOFA and APACHE II, is a 0– 6 scale to reflect the severity of sepsis. AUC at 30, 60, and 90 days was 0.816, 0.815, and 0.820, respectively. K-M curves across six prognostic time periods in both databases showed survival probabilities with different RDW segments and RAAS scores. In the calibration curve, the results of the internal validation of the primary cohort and the results of the external validation cohort showed the prognostic accuracy of RAAS. Conclusion: The RAAS score system is a novel and reliable indicator to predict the short-term and medium-term mortality of patients with sepsis. With the increase of the RAAS score, the mortality of patients with sepsis gradually increases.
About Me
Chengjin Gao specializes in emergency medicine and has published several SCI papers.
https://orcid.org/0000-0002-6867-8024.
Chengjin Gao specializes in emergency medicine and has published several SCI papers.
https://orcid.org/0000-0002-6867-8024.